Andreana Foresta Selected Research

Andreana Foresta Research Topics

2	COVID-19 01/2023 - 01/2022
2	Myocardial Infarction 01/2022 - 01/2022
2	Stroke (Strokes) 01/2022 - 04/2021
1	Ischemic Stroke 02/2024
1	Inflammation (Inflammations) 01/2023
1	ST Elevation Myocardial Infarction 10/2022
1	Non-ST Elevated Myocardial Infarction 10/2022
1	Type 2 Diabetes Mellitus (MODY) 01/2022
1	Heart Failure 01/2022
1	Neoplasms (Cancer) 01/2022
1	Unstable Angina 01/2022
1	Thromboembolism 01/2022
1	Severe Acute Respiratory Syndrome 01/2022
1	Atrial Fibrillation 04/2021
1	Liver Diseases (Liver Disease) 04/2021

2	Glucagon-Like Peptide 1 (GLP 1)IBA 01/2023 - 01/2022
2	Glucagon-Like Peptide-1 Receptor AgonistsIBA 01/2023 - 01/2022
2	Hypoglycemic Agents (Hypoglycemics)IBA 01/2023 - 01/2022
2	AnticoagulantsIBA 01/2022 - 04/2021
1	Insulin (Novolin)FDA Link 02/2024
1	SodiumIBA 01/2023
1	Glucose (Dextrose)FDA LinkGeneric 01/2023
1	ORALIT (ORS)IBA 10/2022
1	omega-Chloroacetophenone (Mace)IBA 01/2022
1	Atorvastatin (Lipitor)FDA Link 01/2022
1	Peptidyl-Dipeptidase A (Angiotensin Converting Enzyme)IBA 01/2022
1	Metformin (Glucophage)FDA LinkGeneric 01/2022
1	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 01/2022
1	Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)IBA 01/2022
1	Ramipril (Altace)FDA LinkGeneric 01/2022
1	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 01/2022
1	Sodium-Glucose Transporter 2 InhibitorsIBA 01/2022

1	Therapeutics 01/2023
1	Secondary Prevention 01/2022